MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • MDS Virtual Congress 2021

    Predicting MDS-UPDRS Ratings for Deep Brain Stimulation Patients Using Wearable Sensor Data

    J. Watts, A. Khojandi, M. Niethammer, R. Ramdhani (Knoxville, USA)

    Objective: To predict gait and speech scores of the (MDS)-Unified Parkinson’s Disease Rating Scale (UPDRS) for chronic subthalamic deep brain stimulation (STN-DBS) patients using wearable…
  • MDS Virtual Congress 2021

    Accuracy in Detection of Performance of Activities of Daily Living in Subjects with Parkinson’s Disease by Using Inertial Sensors and Decision Tree Classifiers

    AI. Perez Sanpablo, J. Quinzanos-Fresnedo, C. Hernandez Arenas, A. Meneses-Penaloza, A. Gonzalez-Mendoza, JC. Castro Padilla, I. Quinones-Uriostegui, V. Bueyes-Roiz, Y. Quijano-Gonzalez, A. Alessi-Montero (Mexico City, Mexico)

    Objective: To obtain an accurate method for the detection of activities of daily living (ADL) in subjects with Parkinson’s disease (PD) by using inertial sensors…
  • MDS Virtual Congress 2021

    My hands are shaking : A Tunisian cohort study

    M. Akkari, S. Zakaria, M. Zouari (Tunis, Tunisia)

    Objective: Analysis of a cohort of patients diagnosed with tremor concerning the epidemiology, clinical features and etiologies. Background: Tremor is the most common movement disorder…
  • MDS Virtual Congress 2021

    Supervised, home-based, real-time videoconferencing telerehabilitation preserves perception of some clinical aspects in people with Parkinson’s disease: preliminary data of a retrospective study

    E. Tardelli, E. Okamoto, F. Almeida, AM. Neto, E. Barbosa, C. Batista (São Paulo, Brazil)

    Objective: To compare retrospectively the effects of 10 months of supervised, home-based, real-time videoconferencing telerehabilitation (RTT) and usual care without exercise training (UC) on self-reported…
  • MDS Virtual Congress 2021

    Parkinson’s Disease Clinical Progression in Latino Patients

    A. Duarte Folle, C. Kusters, K. Paul, B. Ritz, M. Flores, J. Bronstein, A. Keener (Los Angeles, USA)

    Objective: To compare clinical progression of PD in Latino and White Non-Latino (WNL) patients enrolled in a community-based study, exploring potential disparities and what might…
  • MDS Virtual Congress 2021

    Distinct patterns of dyskinetic and dystonic features following D1 or D2 receptor stimulation in a mouse model of parkinsonism

    L. Andreoli, M. Abbaszadeh, X. Cao, A. Cenci Nilsson (Lund, Sweden)

    Objective: We set out to compare patterns of dyskinetic behaviours induced by the systemic administration of L-DOPA and D1 or D2 receptor (D1R, D2R) agonists…
  • MDS Virtual Congress 2021

    Analysis of handgrip strength, upper limb traction and ground reaction force on bus step climb in healthy elderly subjects and individuals with Parkinson’s disease

    A. Miri, H. Gonçalves Araújo, A. Gil, E. Angelo, R. Volpe, B. Masson, A. da Silva, S. Smaili (Londrina, Brazil)

    Objective: To analyze and compare the strength hand, upper limbs traction strength and the ground reaction force (FRS) during step up in a bus, in…
  • MDS Virtual Congress 2021

    Efficacy of opicapone according to levodopa’s duration of use in Parkinson’s disease patients with motor fluctuations

    A. Antonini, G. Ebersbach, O. Rascol, D. Magalhaes, J. Rocha, P. Soares-da-Silva (Padova, Italy)

    Objective: To evaluate the efficacy of opicapone (OPC) in Parkinson’s disease (PD) patients with motor fluctuation (MF) according to levodopa’s duration of use. Background: OPC…
  • MDS Virtual Congress 2021

    The ADOPTION (eArly levoDopa with Opicapone in Parkinson’s paTients wIth motOr fluctuatioNs) study in Parkinson’s disease: design and rationale of a randomized prospective, open-label exploratory trial

    J. Ferreira, W. Poewe, O. Rascol, F. Stocchi, A. Antonini, R. Costa, D. Magalhães, J. Rocha, P. Soares-da-Silva (Lisbon, Portugal)

    Objective: This study aims to explore the potential of opicapone (OPC) to optimize levodopa (L-dopa)/dopa decarboxylase inhibitor (DDCi) as first-line approach to treat wearing-off in…
  • MDS Virtual Congress 2021

    OPTI-ON: A Longitudinal Real-World Study of Opicapone in Patients with Parkinson’s Disease and Motor Fluctuations

    P. Lewitt, O. Klepitskaya, L. Bahroo, G. Liang, S. Rattana, J. Trotter, M. Serbin (West Bloomfield, USA)

    Objective: To conduct a longitudinal real-world study that examines treatment patterns, clinical outcomes, safety and tolerability of opicapone as an adjunctive treatment to carbidopa/levodopa (CD/LD)…
  • « Previous Page
  • 1
  • …
  • 430
  • 431
  • 432
  • 433
  • 434
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley